Free Trial
→ Palantir and Wall Street are in on it… (From Monument Traders Alliance) (Ad)tc pixel Free OXB Stock Alerts

Oxford Biomedica (OXB) Stock Chart & Stock Price History

Oxford Biomedica logo
GBX 538 +17.00 (+3.26%)
As of 08:29 AM Eastern
Compare

Oxford Biomedica Stock Price Performance

5 Day
Performance
+1.89%
1 Month
Performance
+21.17%
3 Month
Performance
-11.95%
Year-To-Date
Performance
-12.80%
1 Year
Performance
-16.33%
5 Year
Performance
-63.25%

OXB Stock Chart for Monday, October, 12, 2026

30 Days 90 Days 1 Year

The Oxford Biomedica (OXB) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has decreased 16.33%, with a year-to-date return of -12.80%. In the past month, the stock has increased 21.17%, reflecting recent market activity.

As of the latest close, Oxford Biomedica traded at GBX 521 with a market cap of £630.66 million and volume of 147,276 shares. Five years ago, the stock traded at GBX 1,464, representing a 63.25% decrease over that period. At the time, it had a market cap of £1.26 billion and a volume of 108,915 shares. View the advanced OXB chart on TradingView.

Receive OXB Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Oxford Biomedica and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

Oxford Biomedica Stock Price History

Price Date
0 Results
DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization
10/09/2026GBX 513GBX 521
+1.56%		GBX 531GBX 513147,276 shs£630.66 million
10/08/2026GBX 528GBX 513
-2.84%		GBX 526.67GBX 512432,783 shs£620.98 million
10/07/2026GBX 531GBX 528
-0.56%		GBX 533GBX 518362,490 shs£639.13 million
10/06/2026GBX 544GBX 531
-2.39%		GBX 563GBX 531863,207 shs£642.77 million
10/05/2026GBX 544GBX 544GBX 546GBX 530432,137 shs£658.50 million
10/02/2026GBX 509.67GBX 544
+6.74%		GBX 558GBX 502706,678 shs£658.50 million
10/01/2026GBX 522GBX 509.67
-2.36%		GBX 530GBX 509347,118 shs£616.94 million
09/30/2026GBX 504GBX 522
+3.57%		GBX 529GBX 50815.48 million shs£631.87 million
09/29/2026GBX 515GBX 504
-2.14%		GBX 524GBX 5041.02 million shs£610.08 million
09/28/2026GBX 507GBX 515
+1.58%		GBX 515GBX 499259,621 shs£623.40 million
09/25/2026GBX 492GBX 507
+3.05%		GBX 507GBX 488.50373,239 shs£613.71 million
09/24/2026GBX 483GBX 492
+1.86%		GBX 498.50GBX 475.5015.36 million shs£595.56 million
09/23/2026GBX 488GBX 483
-1.02%		GBX 518GBX 478650,515 shs£584.66 million
09/22/2026GBX 465GBX 488
+4.95%		GBX 498GBX 449945,696 shs£590.71 million
09/21/2026GBX 460GBX 465
+1.09%		GBX 484GBX 4477.75 million shs£562.87 million
09/18/2026GBX 458.50GBX 460
+0.33%		GBX 467GBX 457279,331 shs£556.82 million
09/17/2026GBX 449.50GBX 458.50
+2.00%		GBX 467.50GBX 450.50374,419 shs£555.01 million
09/16/2026GBX 461GBX 449.50
-2.49%		GBX 462.50GBX 437.25804,293 shs£544.11 million
09/15/2026GBX 438GBX 461
+5.25%		GBX 470GBX 437.5512.14 million shs£558.03 million
09/14/2026GBX 444GBX 438
-1.35%		GBX 450GBX 430.50686,999 shs£530.19 million
Related Companies

This page (LON:OXB) was last updated on 10/12/2026 by MarketBeat.com Staff.
From Our Partners
Fox News: Wall Street Can Seize Your Retirement
Fox News reported that under current law, legal title to most stocks and bonds sits with a central institution...
Monetary Gold | Sponsoredtc pixel
Trump's about to unleash his Midterm Weapon
Trump is turning the midterms into a referendum on American energy, pushing for more oil, more gas, and lower ...
Monument Traders Alliance | Sponsoredtc pixel
Urgent Attention to Executive Order #14363 (Buy This Stock Before Oct. 20th
Marc Chaikin, a 60-year Wall Street veteran whose past clients include George Soros and Steve Cohen, built a s...
Chaikin Analytics | Sponsoredtc pixel
Trump To Relaunch USD?
President Trump's summit with Xi Jinping drew headlines for tariffs and trade truces, but the real story may b...
Porter & Company | Sponsoredtc pixel
Urgent: Invest In ‘Elon’s iPhone’ Before July 22nd
Early Apple investors saw peak gains as high as 7,537% after the iPhone launched. Now, multiple insider source...
StocksToTrade | Sponsoredtc pixel
Your book is inside
The "Sucker's Bet" Most New Options Traders Fall For Most people who try options lose money the same way. ...
Profits Run | Sponsoredtc pixel
The smarter SpaceX play most investors will miss
When two of my analysts started bringing me memecoin wins, I was skeptical. It looked like a hot streak that c...
Crypto 101 Media | Sponsoredtc pixel
Why major institutions are piling into this digital asset now
BlackRock, JPMorgan, Goldman Sachs, and Fidelity are reportedly accumulating a scarce blockchain asset - one t...
Awesomely | Sponsoredtc pixel